SEARCH
Reporter's Take | GSP withdrawal may hit US margins of Indian drug cos.
Moneycontrol
2019-06-03
Views
343
Description
Share / Embed
Download This Video
Report
Moneycontrol’s Vaibhavi Khanwalkar gets in conversation with Viswanath Pilla to know more about the ‘GSP withdrawal may hit US margins of Indian drug cos.’and more …
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x7a5q8e" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
04:15
Reporter's Take | Rising OAIs raises concern for Indian drug cos.
02:31
3 Point Analysis | Nestle Q4 Profit up 10%, Margins Hit
03:44
Reporter's Take | Anti-trust case spooks Indian generic drug companies
03:27
Ideas for Profit | AC companies post decent revenue growth in Q3, but margins contract sharply
04:21
Ideas for Profit | Titan Q3: Jewellery sparkles; margins in watches and eyewear disappoint
03:20
Ideas for Profit | Asian Paints: Time for caution as margins miss expectations & valuations rich
03:30
Ideas for Profit | Titan posts strong Q4 sales growth, but one-offs cause margins to contract
02:29
3 Point Analysis | Thermax Q4: Good show, margins remain a key concern
03:21
Ideas for Profit | Receding cost pressures to aid margin recovery in tile and sanitaryware cos
03:26
Reporter's Take | US firms attracting rich Indians with EB-5 visas
02:33
Reporter's Take | Fewer Indians applying for US B-schools
02:38
Reporter's Take | No Indian university in top 300 global list